Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in Healthy Volunteers Aged Above 2 Months
A Single-center, Open, Phase I Clinical Trial to Evaluate Safety of 15-Valent Pneumococcal Conjugate Vaccine in Healthy Volunteers Aged Above 2 Months
Sponsor: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
This PHASE1 trial investigates Pneumonia, Pneumococcal and is currently ongoing. Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd leads this study, which shows 5 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE1
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status PHASE1
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Recruiting PHASE1
-
Oct 2019 — Jan 2021 [monthly]
Recruiting PHASE1
First recorded
Jun 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
- Hebei Center for Disease Control and Prevention
- Laishui Center for Disease Control and Prevention
- National Institutes for Food and Drug Control, China
- Simoon Record Pharma Information Consulting Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .